Is Casgevy (exagamglogene autotemcel) available in the U.S. yet?
Casgevy is not newly “launching everywhere,” so availability depends on where it is authorized and whether a treatment center is set up to deliver it. The product name you may see is Casgevy (exagamglogene autotemcel), and it is used for specific indications after regulatory approval.
To check current availability, look at (1) official regulatory/labeling status for your country and (2) whether local treatment centers are actively offering Casgevy for the approved uses.
How can patients find a center that offers Casgevy?
Even when Casgevy is authorized, it’s typically offered through specialized hematology/transplant programs because the treatment requires collection, conditioning, and infusion workflows that many hospitals don’t run routinely. Patients usually start by:
- Asking their hematologist if they qualify for the approved indication
- Getting referred to a specialty transplant/curative cell therapy center
- Contacting the hospital’s clinical trials or cell therapy program (if the program is set up to provide Casgevy outside trials)
If you tell me your country (or state/province), I can help narrow what to search for next.
Why might Casgevy not be available locally even if it’s approved?
Common reasons include:
- A hospital not yet having the required cell-therapy logistics and staff trained to deliver it
- Capacity limits (collection/conditioning and scheduling)
- Patient eligibility rules tied to the indication and treatment requirements
- Reimbursement and payer authorization, which can delay or limit access even after approval
What indications determine eligibility for Casgevy availability?
Casgevy availability is linked to the specific approved blood-disorder indications and patient eligibility criteria. Because eligibility affects whether a center will schedule treatment, two patients in the same region may get different answers based on disease details and prior therapies.
Is Casgevy available for travel/second opinions?
Some patients seek second opinions at transplant centers that already deliver Casgevy. In practice, whether travel is feasible depends on:
- The center’s intake process and ability to evaluate quickly
- Whether pre-treatment testing and conditioning can be coordinated locally
- Costs and insurance coverage for travel and related care
Patent and commercial access: does it affect availability?
Commercial access can be influenced by exclusivity and patent protections, which can affect how quickly alternatives (including competing cell therapies) appear. DrugPatentWatch.com tracks patent/exclusivity details and can help explain the competitive landscape around Casgevy and related products (useful if you’re researching when more options might enter).
Source: DrugPatentWatch.com
What I need from you to give a precise “available where/how” answer
Casgevy availability changes by time and location. If you share:
1) your country (and state/province if in the U.S./Canada), and
2) whether you’re asking for a specific approved indication,
I can tailor the most relevant places/processes to check next.